Valeur202020212022202320242025TTMFrais de vente, généraux et administratifs5.36 B6.43 B6.46 B7.13 B7.68 B8.65 B8.63 BRecherche et développement984 M1.24 B1.45 B1.39 B1.47 B1.62 B1.63 BRésultat d'exploitation2.22 B2.58 B2.84 B3.89 B3.69 B4.89 B4.99 BTotal des produits hors exploitation-269 M-303 M-158 M-215 M-197 M232 M230 MCharges d'intérêts, nettes des intérêts capitalisés315 M337 M337 M356 M396 M607 M593 MRésultat hors exploitation, hors charges d'intérêts-269 M-303 M-158 M-215 M-197 M-375 M-363 MRevenus/dépenses exceptionnels———————Résultat avant impôts1.95 B2.28 B2.68 B3.67 B3.49 B4.51 B4.6 BPart des actionnaires dans le résultat———————Impôts355 M287 M325 M508 M499 M1.27 B1.26 BIntérêts ne donnant pas le contrôle / intérêts minoritaires———————Autres produits/charges après impôts———————Résultat net avant activités abandonnées1.6 B1.99 B2.36 B3.17 B2.99 B3.25 B3.34 BActivités abandonnées———————Résultat net1.6 B1.99 B2.36 B3.17 B2.99 B3.25 B3.34 BAjustement de dilution———————Dividendes privilégiés———————Résultat net dilué revenant aux actionnaires ordinaires1.6 B1.99 B2.36 B3.17 B2.99 B3.25 B3.34 BBénéfice par action de base (BPA de base)4.265.296.238.347.868.498.73Bénéfice par action dilué (BPA dilué)4.25.216.178.257.768.48.64Nombre moyen d'actions de base en circulation375.5 M377 M378.2 M379.6 M381 M382.2 M—Nombre d'actions en circulation après dilution380.3 M382.3 M382.2 M383.7 M385.6 M386.5 M—EBITDA3.3 B3.86 B4.12 B5.23 B5.12 B6.46 B6.59 BEBIT2.22 B2.58 B2.84 B3.89 B3.69 B4.89 B4.99 BCoût des ventes5.29 B6.14 B6.87 B7.44 B8.15 B9.05 B9.14 BAutres coûts des ventes———————Amortissements (flux de trésorerie)1.08 B1.27 B1.28 B1.34 B1.43 B1.57 B1.61 B
Stryker Corporation Common Stock
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States.
The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000.